Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
AML
secondary
trials
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 Nov 2020
11 Nov 2020
Historique:
received:
11
10
2020
revised:
05
11
2020
accepted:
08
11
2020
entrez:
14
11
2020
pubmed:
15
11
2020
medline:
15
11
2020
Statut:
epublish
Résumé
We report the outcomes of secondary acute myeloid leukemia (s-AML) patients included in one of 13 European Organisation for Research and Treatment of Cancer (EORTC) collaborative AML trials using intensive remission-induction chemotherapy. Among 8858 patients treated between May 1986 and January 2008, 960 were identified as having s-AML, either after MDS (cohort A;
Identifiants
pubmed: 33187229
pii: cancers12113334
doi: 10.3390/cancers12113334
pmc: PMC7697114
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondation contre le Cancer
ID : grant to EORTC
Organisme : Fonds De La Recherche Scientifique - FNRS
ID : FB Senior research associate mandate
Références
Blood. 2001 Oct 15;98(8):2326-31
pubmed: 11588026
Blood Adv. 2017 Jul 19;1(17):1312-1323
pubmed: 29296774
Br J Haematol. 2020 Feb;188(3):428-437
pubmed: 31612473
JAMA Oncol. 2017 Jul 1;3(7):936-943
pubmed: 28152123
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10
pubmed: 25516983
Blood Adv. 2018 Aug 28;2(16):2127-2135
pubmed: 30143527
N Engl J Med. 2010 Nov 25;363(22):2091-101
pubmed: 21105791
Leuk Res. 2018 Jun 1;70:91-96
pubmed: 29908418
Leukemia. 2014 Feb;28(2):289-92
pubmed: 23760400
Ann Hematol. 2016 Jan;95(2):191-9
pubmed: 26596971
J Clin Oncol. 2014 Jan 20;32(3):219-28
pubmed: 24297940
Am J Hematol. 2015 Mar;90(3):208-14
pubmed: 25421221
J Clin Oncol. 2009 Nov 10;27(32):5397-403
pubmed: 19826132
N Engl J Med. 1995 Jan 26;332(4):217-23
pubmed: 7808487
Haematologica. 2019 Jun;104(6):1168-1175
pubmed: 30523055
Ann Hematol. 2012 Jun;91(6):825-35
pubmed: 22460947
Ann Hematol. 2015 Dec;94(12):1981-9
pubmed: 26410352
Leukemia. 1995 Nov;9(11):1805-11
pubmed: 7475266
J Clin Oncol. 2013 Dec 10;31(35):4424-30
pubmed: 24127442
J Clin Oncol. 2018 Sep 10;36(26):2684-2692
pubmed: 30024784
Haematologica. 1999 Oct;84(10):937-45
pubmed: 10509043
Haematologica. 2004 Aug;89(8):950-6
pubmed: 15339678
J Clin Oncol. 2015 Nov 1;33(31):3641-9
pubmed: 26304885
J Intern Med. 2019 Apr;285(4):407-418
pubmed: 30372796
Lancet Haematol. 2015 Oct;2(10):e427-36
pubmed: 26686044
Blood. 2019 Mar 28;133(13):1457-1464
pubmed: 30630862
Blood. 2005 Jul 1;106(1):27-34
pubmed: 15761020
Blood. 2010 Jul 22;116(3):354-65
pubmed: 20385793
J Clin Oncol. 2008 Oct 10;26(29):4791-7
pubmed: 18695255
Haematologica. 2020 Jan;105(1):e13-e16
pubmed: 31097634
J Clin Oncol. 1998 Mar;16(3):872-81
pubmed: 9508168
Lancet Oncol. 2017 Jan;18(1):100-111
pubmed: 27923552
Haematologica. 2010 Oct;95(10):1754-61
pubmed: 20494931
Leukemia. 2006 Oct;20(10):1723-30
pubmed: 16932345